Study for treatment of urothelial or bladder cancer
This study is for the treatment of advanced transitional cell carcinoma.
Primary disease category: Cancer
Sponsor: Southwest Oncology Group
Protocol number: C90601
Projected enrollment dates: January 2014 to June 2019
Official study title: A Randomized Double-Blinded, Placebo-Controlled Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma